Home » World Health Organization (WHO) » Page 15

World Health Organization (WHO)

CND intersessional – 23 February 2017: Preparations for the 62nd Session in 2019

WHO: The role of the WHO is to determine whether drugs and NPS should be controlled or, if controlled, if their schedule should be changed. This decision is made by the ECDD with decisions made on scientific grounds. Elements considered include: likelihood of abuse (compared with existing controlled substances), convertibility into existing controlled substances, degree …

Read more

CND 59th Session Reconvened – Friday 2nd December

Session started with administrative issues and the adoption of the budget resolution – amended from Monday after FINGOV meeting (E/CN.7/2016/L.16 – Implementation of the budget 2016/2017 for the UN drug control programme). Agenda item 6. Implementation of the international drug control treaties. Chair: Under this item we have invited the WHO to present to present …

Read more

CND Intersessional Meeting – 27 October 2016: Evolving reality, trends and existing circumstances and threats, including NPS

CND Chair. For a more efficient use of time, let’s start with agenda items 2 and 3, and will then give word to Ambassador Pedro Moitinha, Post-UNGASS Chair. Agenda item 2 – Arrangements for the reconvened and 60th CND.  On the 59th Reconvened, we decided to hold an extra day on UNGASS on 30th November …

Read more

CND Intersessional Meeting – 10 October: Operational recommendations on Ensuring the availability of and access to controlled substances exclusively for medical and scientific purposes, while preventing their diversion

Gilberto Gerra, UNODC: There is a clear imbalance in terms of access to essential medicines. The UNGASS outcome document contemplates measures to facilitate this. Ethical mandate to reduce burden of pain. Countries have produced a myriad of supplementary regulations that restrict access and go beyond international obligations: burdensome registration of patients, specific permissions for doctors, …

Read more

CND Intersessional Meeting – 10 October: Operational recommendations on Demand reduction and related measures, including prevention and treatment, as well as other health-related issues

CND Chair: I propose that we tackle the more logistical agenda items 2 and 3 first, before moving onto the thematic discussions (agenda item 1). Agenda item 2 – plans for the reconvened 59th CND (December) and the 60th CND (March). New nominees have been put forward for 2nd Vice-Chair (Brazil) and 3rd Vice-Chair (Nigeria). …

Read more